A general neurologist's perspective on the urgent need to apply resilience thinking to the prevention and treatment of Alzheimer's disease
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
UMass Chan Affiliations
Department of Medicine, Division of Preventive and Behavioral MedicineDepartment of Neurology
Document Type
Journal ArticlePublication Date
2017-11-01Keywords
AdaptabilityAllostasis
Allostatic load
Allostatic overload
Complex system
Panarchy
Resilience
Resilience thinking
Transformability
Mental Disorders
Nervous System Diseases
Neurology
Preventive Medicine
Social and Behavioral Sciences
Translational Medical Research
Metadata
Show full item recordAbstract
The goal of this article was to look at the problem of Alzheimer's disease (AD) through the lens of a socioecological resilience-thinking framework to help expand our view of the prevention and treatment of AD. This serious and complex public health problem requires a holistic systems approach. We present the view that resilience thinking, a theoretical framework that offers multidisciplinary approaches in ecology and natural resource management to solve environmental problems, can be applied to the prevention and treatment of AD. Resilience thinking explains a natural process that occurs in all complex systems in response to stressful challenges. The brain is a complex system, much like an ecosystem, and AD is a disturbance (allostatic overload) within the ecosystem of the brain. Resilience thinking gives us guidance, direction, and ideas about how to comprehensively prevent and treat AD and tackle the AD epidemic.Source
Alzheimers Dement (N Y). 2017 Sep 12;3(4):498-506. doi: 10.1016/j.trci.2017.08.001. eCollection 2017 Nov. Link to article on publisher's site
DOI
10.1016/j.trci.2017.08.001Permanent Link to this Item
http://hdl.handle.net/20.500.14038/40442PubMed ID
29124107Related Resources
Rights
Copyright 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).Distribution License
http://creativecommons.org/licenses/by-nc-nd/4.0/ae974a485f413a2113503eed53cd6c53
10.1016/j.trci.2017.08.001
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).